All In MedTech

FDA Clearance Tracker · P060010

THE SPANNER TEMPORARY PROSTATIC STENT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 14, 2006 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

Dec 14, 2006

Approved

Time to decision

275 days

Received Mar 14, 2006. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P060010
Device name
THE SPANNER TEMPORARY PROSTATIC STENT
Applicant
Srs Medical
Applicant location
North Billerica, MA
Received
Mar 14, 2006
Decided
Dec 14, 2006
Decision
Approved
Supplements
13 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NZC

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SPANNER TEMPORARY PROSTATIC STENT. THE DEVICE IS INTENDED FOR TEMPORARY USE (UP TO 30 DAYS) TO MAINTAIN URINE FLOW AND ALLOW VOLUNTARY URINATION IN PATIENTS FOLLOWING MINIMALLY INVASIVE TREATMENT FOR BENIGN PROSTATIC HYPERPLASIA (BPH) AND AFTER INITIAL POST-TREATMENT CATHETERIZATION.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code NZC (Stent, urethral, prostatic, semi-permanent).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Srs Medical

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.